Pain

Pain
Audio Summaries

Every issue of Pain moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.

32 audio summariesNLM Catalog

Specialties

Pain covers research in these specialties.

Recent summaries

The latest articles summarized from Pain.

Life course trajectories of musculoskeletal pain.

Nov 2, 2026

This study used a Swedish population-representative survey, following 6,328 people over 42 years (ages 15 to 101) to examine how musculoskeletal pain in the joints, back, or shoulders develops across the adult life course. Sex-stratified latent class growth analysis identified two trajectories for both women and men: a high-risk group (20% of women, 9% of men) whose pain rose throughout working age and declined after retirement, and a low-pain group whose pain exceeded light levels only after retirement age. The authors suggest the high-risk group may reflect cumulative working-life risk factors, while the late-life increase likely reflects normal ageing, and they argue that sample-wide averages obscure this distinct high-risk pattern.

Spontaneous neuropathic pain.

Nov 2, 2026

This review argues that spontaneous neuropathic pain should be treated as a distinct symptom domain, separate from stimulus-evoked hypersensitivity, because the two arise from dissociable molecular, cellular, and circuit mechanisms. The authors ask whether current preclinical models, trials, and treatment guidelines, which have focused mainly on evoked pain, contribute to a mismatch between mechanisms and therapies. They propose that ectopic activity from injured sensory fibers drives spontaneous pain, and that longitudinal, biomarker-informed phenotyping could enable symptom-aligned, mechanism-based treatments.

Brain sites involved in endogenous analgesia.

Nov 2, 2026

This review synthesizes animal and human evidence on the brain circuits that mediate endogenous pain modulation, asking which core pathways regulate nociception and how they change in chronic pain. The authors focus on the best-characterized descending pathway, running from the midbrain periaqueductal gray to the rostral ventromedial medulla and onward to the spinal or trigeminal dorsal horn. They also highlight how ultra-high-field fMRI now allows millimeter-scale imaging of brainstem nuclei in humans, enabling direct study of this circuitry.

Under pressure: lessons from and beyond entrapment neuropathies.

Nov 2, 2026

Entrapment neuropathies are increasingly understood as biologically dynamic conditions rather than purely mechanical compression, involving microvascular compromise, demyelination, axonal degeneration, immune and neuroinflammatory processes, central adaptations, and psychosocial factors. This review asks how the variable mix of these biopsychosocial mechanisms explains the clinical heterogeneity and diagnostic discordances seen even within the same diagnosis, such as extraterritorial symptoms and normal electrodiagnostic results. The authors also argue that entrapment neuropathies offer a natural human model of focal nerve injury whose lessons can inform mechanism-based treatment of neuropathic and nerve-related musculoskeletal pain more broadly.

Advances in research on combination therapy for the management of pain.

Nov 2, 2026

This review examines whether combining analgesic drugs from different mechanistic classes provides superior pain relief and fewer side effects than single-drug treatment. The authors note that about half of chronic pain patients (and more with acute pain) already receive such combinations, yet many lack rigorous supporting evidence. They propose five steps to better evaluate combination therapy, including multi-dose preclinical testing, clinical trials comparing each monotherapy component, real-world studies, and extending these principles to nonpharmacological treatments.

Chloride dysregulation: the next target for chronic pain therapeutics.

Nov 2, 2026

This review argues that chronic pain treatments have failed because they suppress normal pain signaling rather than correcting the pathological mechanisms specific to chronic pain. The author highlights injury-induced loss of the chloride transporter KCC2 in spinal dorsal horn neurons as a mechanism for inhibitory failure that can explain key neuropathic pain symptoms, and shows how chloride dysregulation produces counterintuitive effects, such as benzodiazepines potentially becoming pro-excitatory. The paper positions KCC2 as a promising therapeutic target for both analgesia and disease modification.

Exercise therapy for chronic pain: an updated perspective on mesocorticolimbic system function.

Nov 2, 2026

This review examines how exercise therapy may relieve chronic pain by restoring mesocorticolimbic system function, asking whether exercise can reverse the pain-related dysfunction of brain reward and emotion circuits. The authors outline peripheral mechanisms (such as muscle-derived IGF-1 crossing the blood-brain barrier to activate orexin and dopamine neurons), central circuit changes (such as amygdala pathways to the nucleus accumbens), and serotonergic and epigenetic effects in the dorsal raphe nucleus that may underlie depression. They conclude that exercise may restore brain function and support exercise therapy as a key component of chronic pain management.

Prediction and prevention of pain after surgery.

Nov 2, 2026

This review examines how to predict and prevent the transition from acute to chronic postsurgical pain, integrating clinical evidence with mechanistic insights from preclinical models. The authors argue that current risk tools lack sufficient precision and generalizability, and that risk emerges dynamically across pre-, intra-, and postsurgical phases. They propose integrating biological, psychological, and social factors into clinically useful prognostic models to enable mechanism-based, personalized prevention in vulnerable patients.

Molecular histochemical analysis of neuroplasticity-related gene expression in pain pathway.

Nov 2, 2026

This review by Koichi Noguchi, written on receipt of the 2026 John Bonica Prize, synthesizes four decades of animal-model research on the molecular mechanisms of chronic pain. It asks how neuroplasticity-related gene expression changes in the dorsal root ganglion and spinal cord shape the sustained pain signaling underlying intractable pain. The paper also reviews methodological advances in integrating histochemistry, molecular biology, behavior, and electrophysiology, and discusses challenges and future directions for basic pain research.

The neuropathic chameleon: we are hot on the scent.

Nov 2, 2026

This review addresses why neuropathic pain treatments have largely failed, pointing to the condition's heterogeneous, mechanism-driven pathophysiology rather than its disease etiology. The authors ask how mechanism-based phenotyping could enable a priori patient stratification, given that no validated biomarkers for pain mechanisms currently exist. They evaluate candidate predictive and surrogate markers, focusing on sensory symptoms and signs assessed through patient-reported outcomes and quantitative sensory testing, and discuss how these could be integrated into future clinical trials.

Listen to Pain

14-day free trial. Every new article, summarized in ~3 minutes.